ZA864051B - Anti-cancer quinazoline derivatives - Google Patents

Anti-cancer quinazoline derivatives

Info

Publication number
ZA864051B
ZA864051B ZA864051A ZA864051A ZA864051B ZA 864051 B ZA864051 B ZA 864051B ZA 864051 A ZA864051 A ZA 864051A ZA 864051 A ZA864051 A ZA 864051A ZA 864051 B ZA864051 B ZA 864051B
Authority
ZA
South Africa
Prior art keywords
group
heteroatom
quinazoline derivatives
halogeno
chem
Prior art date
Application number
ZA864051A
Other languages
English (en)
Inventor
Ann Lesley Jackman
David Richard Newell
Terence Richard Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of ZA864051B publication Critical patent/ZA864051B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA864051A 1985-05-31 1986-05-30 Anti-cancer quinazoline derivatives ZA864051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513754A GB8513754D0 (en) 1985-05-31 1985-05-31 Anti-cancer quinazoline derivatives

Publications (1)

Publication Number Publication Date
ZA864051B true ZA864051B (en) 1987-01-28

Family

ID=10579966

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864051A ZA864051B (en) 1985-05-31 1986-05-30 Anti-cancer quinazoline derivatives

Country Status (17)

Country Link
US (1) US5236927A (xx)
EP (1) EP0204529B1 (xx)
JP (1) JPS61282368A (xx)
AT (1) ATE87621T1 (xx)
AU (1) AU592271B2 (xx)
DE (1) DE3688150T2 (xx)
DK (1) DK255786A (xx)
ES (1) ES8800911A1 (xx)
FI (1) FI862303A (xx)
GB (2) GB8513754D0 (xx)
GR (1) GR861418B (xx)
HU (1) HUT45512A (xx)
IL (1) IL78910A0 (xx)
NO (1) NO862170L (xx)
NZ (1) NZ216363A (xx)
PT (1) PT82682B (xx)
ZA (1) ZA864051B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
US7262058B2 (en) * 2001-03-09 2007-08-28 Nonda Katopodis Method for determining lipid associated sialoprotein in body fluids
BR0315403A (pt) * 2002-10-18 2005-08-16 Koninkl Philips Electronics Nv Método, sistema, e dispositivo de assinatura para prover autenticação de integridade de dados e proteção de dados, dispositivo de verificação para verificar autenticação de integridade de dados e proteção de dados, sinal compreendendo fragmentos de dados, e, produto de programa de computador
JP2006512315A (ja) * 2002-11-04 2006-04-13 エヌピーエス ファーマスーティカルズ インコーポレイテッド カルシリティックとしてのキナゾリノン化合物
WO2007011618A1 (en) * 2005-07-15 2007-01-25 Schering Corporation Quinazoline derivatives useful in cancer treatment
CN101263125A (zh) * 2005-07-15 2008-09-10 先灵公司 用于癌症治疗的喹唑啉衍生物
MX2009003673A (es) 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
RS56352B2 (sr) * 2009-06-25 2023-02-28 Alkermes Pharma Ireland Ltd Heterociklična jedinjenja za lečenje neuroloških i psiholoških poremećaja
EP2521711B1 (en) * 2010-01-07 2017-08-16 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
ES2691671T3 (es) 2010-06-24 2018-11-28 Alkermes Pharma Ireland Limited Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
LT3156056T (lt) 2011-03-18 2024-02-26 Alkermes Pharma Ireland Limited Farmacinės kompozicijos, apimančios sorbitano esterius
AU2013235519C1 (en) 2012-03-19 2018-04-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
EP2827867B1 (en) 2012-03-19 2019-11-06 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising glycerol esters
JP6333802B2 (ja) 2012-03-19 2018-05-30 アルカームス ファーマ アイルランド リミテッド ベンジルアルコールを含む医薬組成物
EP2897592B1 (en) 2012-09-19 2020-02-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions having improved storage stability
CN106132415A (zh) 2014-03-20 2016-11-16 奥克梅斯制药爱尔兰有限公司 具有增加的注射速度的阿立哌唑制剂
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2024028999A1 (ja) * 2022-08-03 2024-02-08 Ils株式会社 Ｎ－［４－メチルアミノベンゾイル］－ｌ－グルタミン酸ジエチルエステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids
EP0031237B1 (en) 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
DK255786A (da) 1986-12-01
ES555548A0 (es) 1987-12-01
EP0204529A2 (en) 1986-12-10
HUT45512A (en) 1988-07-28
ATE87621T1 (de) 1993-04-15
EP0204529A3 (en) 1987-11-19
JPS61282368A (ja) 1986-12-12
DE3688150D1 (de) 1993-05-06
ES8800911A1 (es) 1987-12-01
GB8613184D0 (en) 1986-07-02
NO862170L (no) 1986-12-01
AU592271B2 (en) 1990-01-04
PT82682A (en) 1986-06-01
DE3688150T2 (de) 1993-07-29
US5236927A (en) 1993-08-17
PT82682B (pt) 1988-03-03
GB2175903B (en) 1988-10-12
NZ216363A (en) 1989-07-27
DK255786D0 (da) 1986-05-30
FI862303A (fi) 1986-12-01
AU5822086A (en) 1986-12-04
EP0204529B1 (en) 1993-03-31
GR861418B (en) 1986-09-26
GB2175903A (en) 1986-12-10
GB8513754D0 (en) 1985-07-03
FI862303A0 (fi) 1986-05-30
IL78910A0 (en) 1986-09-30

Similar Documents

Publication Publication Date Title
GB2175903B (en) Anti-cancer quinazoline derivatives
IE802672L (en) Quinazolines
MX166257B (es) Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo
FR2526659B1 (fr) Medicaments immunomodulants a base de derives de l'acide phenylacetique
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE50773T1 (de) Alkylresorcinolphosphite.
DE3661198D1 (en) Phosphate ester derivatives, and their use as anti-cancer agents
ES2004452A6 (es) Un metodo para aumetar la adhesion de elastomeros de silicona obtenidos a partir de emulsiones acuosas, a substratos
DE3688128D1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
DE3680725D1 (en) Propanolabkoemmlinge.
ES2019633B3 (es) Compuestos de azaantraceno.